Paper41299124
Primary Care Providers Perspectives of GLP-1 Receptor Agonists to Manage Recurrent Weight Gain after Metabolic Bariatric Surgery - a Qualitative Study.
Tolvanen L and 6 others. Obes Surg, 2026. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. Primary Care Providers Perspectives of GLP-1 Receptor Agonists to Manage Recurrent Weight Gain after Metabolic Bariatric Surgery - a Qualitative Study. Papers, record 41299124. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41299124
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Primary Care Providers Perspectives of GLP-1 Receptor Agonists to Manage Recurrent Weight Gain after Metabolic Bariatric Surgery - a Qualitative Study.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bariatric Surgery | Major topic |
| Glucagon-Like Peptide-1 Receptor Agonists | Major topic |
| Weight Gain | Major topic |
| Attitude of Health Personnel | Major topic |
| Physicians, Primary Care | Major topic |
| Humans | |
| Qualitative Research | |
| Female | |
| Male | |
| Middle Aged | |
| Primary Health Care | |
| Adult | |
| United States | |
| Recurrence | |
| Sweden |
Source PubMed
References28
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 39907856 | The Impact of Novel Medications for Obesity on Weight Stigma and Societal Attitudes: A Narrative Review. | Curr Obes Rep | 2025 | https://conductscience.org/library/papers/39907856 | PubMed |
| 2 | 27222548 | Clinical Outcomes of Metabolic Surgery: Efficacy of Glycemic Control, Weight Loss, and Remission of Diabetes. | Diabetes Care | 2016 | https://conductscience.org/library/papers/27222548 | PubMed |
| 3 | 40712620 | International Federation for the Surgery of Obesity statement on metabolic bariatric surgery after pharmacotherapy-induced weight loss in clinical obesity. | Lancet Diabetes Endocrinol | 2025 | https://conductscience.org/library/papers/40712620 | PubMed |
| 4 | 35658024 | Tirzepatide Once Weekly for the Treatment of Obesity. | N Engl J Med | 2022 | https://conductscience.org/library/papers/35658024 | PubMed |
| 5 | 36336720 | 2022 American Society of Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) Indications for Metabolic and Bariatric Surgery. | Obes Surg | 2023 | https://conductscience.org/library/papers/36336720 | PubMed |
| 6 | 39910018 | The Efficacy of Glucagon-like Peptide-1 (GLP-1) Receptor Agonists for Insufficient Weight Loss or Regain After Metabolic/Bariatric Surgery: A Systematic Review and Meta-analysis. | Obes Surg | 2025 | https://conductscience.org/library/papers/39910018 | PubMed |
| 7 | 38561488 | The effect of GLP-1 receptor agonist use on negative evaluations of women with higher and lower body weight. | Int J Obes (Lond) | 2024 | https://conductscience.org/library/papers/38561488 | PubMed |
| 8 | 38660941 | Managing the new wave of weight loss medication in general practice: A qualitative study. | Clin Obes | 2024 | https://conductscience.org/library/papers/38660941 | PubMed |
| 9 | 33567185 | Once-Weekly Semaglutide in Adults with Overweight or Obesity. | N Engl J Med | 2021 | https://conductscience.org/library/papers/33567185 | PubMed |
| 10 | 38969880 | A new framework for the diagnosis, staging and management of obesity in adults. | Nat Med | 2024 | https://conductscience.org/library/papers/38969880 | PubMed |
| 11 | 17356530 | Ten-year trends in health-related quality of life after surgical and conventional treatment for severe obesity: the SOS intervention study. | Int J Obes (Lond) | 2007 | https://conductscience.org/library/papers/17356530 | PubMed |
| 12 | 39612579 | International consensus position statement on the role of obesity management medications in the context of metabolic bariatric surgery: expert guideline by the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO). | Br J Surg | 2024 | https://conductscience.org/library/papers/39612579 | PubMed |
| 13 | 38848064 | Bariatric Metabolic Surgery vs Glucagon-Like Peptide-1 Receptor Agonists and Mortality. | JAMA Netw Open | 2024 | https://conductscience.org/library/papers/38848064 | PubMed |
| 14 | 40316896 | Barriers in prescribing antidiabetic medications with cardiovascular benefits: practice, experience, and attitudes of GPs in Croatia. | BMC Prim Care | 2025 | https://conductscience.org/library/papers/40316896 | PubMed |
| 15 | 39657161 | Behavioral medicine in the GLP-1 era. | Ann Behav Med | 2025 | https://conductscience.org/library/papers/39657161 | PubMed |
| 16 | 40692948 | Primary care patient and practice member perspectives on weight loss medications: challenges and opportunities. | Front Med (Lausanne) | 2025 | https://conductscience.org/library/papers/40692948 | PubMed |
| 17 | 39781548 | Perceptions of Obesity Among Healthcare Professionals and Policy Makers in 2023: Results of the Global OPEN Survey. | Obes Sci Pract | 2025 | https://conductscience.org/library/papers/39781548 | PubMed |
| 18 | 39400870 | Therapeutic Options for Recurrence of Weight and Obesity Related Complications After Metabolic and Bariatric Surgery: An IFSO Position Statement. | Obes Surg | 2024 | https://conductscience.org/library/papers/39400870 | PubMed |
| 19 | 38708040 | Healthcare professionals' perceptions and management of obesity & knowledge of glucagon, GLP-1, GIP receptor agonists, and dual agonists. | Obes Sci Pract | 2024 | https://conductscience.org/library/papers/38708040 | PubMed |
| 20 | 39612581 | Role of obesity-management medications before and after metabolic bariatric surgery: a systematic review. | Br J Surg | 2024 | https://conductscience.org/library/papers/39612581 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42533869 | Understanding obesity treatment choices: a mixed-methods study of patient preferences and shared decision-making. | Transl Behav Med | 2026 | https://conductscience.org/library/papers/42533869 | PubMed |
| 42076118 | Is Oral Semaglutide a Good Fit for Patients After Metabolic Bariatric Surgery? A Biopharmaceutical Mechanistic Perspective. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/42076118 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| GLP1R | 2740 | PubTator's text mining | https://conductscience.org/library/genes/2740 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41299124
GET https://conductscience.org/api/papers/v1/41299124/references?page=2